P. Bhaskara Narayana, Director and Chief Financial Officer of Natco Pharma Ltd, is no more. Bhaskara Narayana had joined Natco Pharma in 2000 and played a key role in the company's growth. Earlier, he had served in VST Industries, Ambhuja Petrochemicals, Mahindra & Mahindra and SOL Pharmaceuticals, among others.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,172 INR | +6.80% | +17.19% | +44.49% |
28/05 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
28/05 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.49% | 2.35B | |
+47.68% | 779B | |
+40.67% | 631B | |
-6.87% | 354B | |
+20.34% | 333B | |
+8.57% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.19% | 163B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Announces Demise of P. Bhaskara Narayana, Director and Chief Financial Officer